Founded in 2012, CardiacSense is a world leading technology company in the science of AFib and heart health monitoring. It has developed a unique, state-of-the-art watch for long-term, continuous monitoring of heart arrhythmias, such as atrial fibrillation (AFib) and vital signs. Based in Israel, the expert multidisciplinary team at CardiacSense combines years of clinical, technical, and business experience. CardiacSense is patent protected for its optical, mechanical, and signal processing capability. The company has conducted numerous clinical studies and is approved as a clinical grade medical device. Offering patients, medical professionals and healthcare organisations assurance that CardiacSense is fully tested and a high-performance wearable watch for the continuous detection and monitoring of AFib and vital signs.